United States · Bill · S
S. 2723 (116th)
Mitigating Emergency Drug Shortages Act
Introduced
29 October 2019
Last action
—
Status
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S6245-6246)
Sponsors
—
Subjects
Discovery layer
Source updated
21 April 2025
Summary
Mitigating Emergency Drug Shortages Act This bill requires the Food and Drug Administration (FDA) to prioritize the review of life-saving or life-sustaining drugs that are facing shortages. The bill also requires manufacturers to report certain information to the FDA when there is a permanent discontinuance or interruption in the manufacture of active pharmaceutical ingredients for such drugs.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate · EN · 29 October 2019
Introduced in Senate (PDF)
Introduced in Senate · EN · 29 October 2019
Introduced in Senate
summary · EN · 29 October 2019
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/116th-congress/senate-bill/2723
- Open data entity: https://api.congress.gov/v3/bill/116/s/2723